Trials / Recruiting
RecruitingNCT06526065
Molecular Mechanisms in Malignant Lymphoma- Predict (MMML Predict)
Molecular Mechanisms in Malignant Lymphoma- Predict
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- University Medical Center Goettingen · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The trial aims at the construction and validation of an accurate, affordable and simple prognostic tool to be used in everyday clinical practice, which allows the early and reliable identification of DLBCL patients who have a very high risk of treatment failure following R-CHOP/-like first-line therapy.
Detailed description
Observational study of 500 recruited and 300 evaluable patients with de novo large cell B Cell lymphoma, age 18-80. Standard guideline recommended treatment by treating physicians discretion. Collection of clinical data, PET-CT data, liquid biopsy, WGSequencing to determine optimal prognostic factors to surpass prediction offered by current IPI.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | no intervention | no intervention |
Timeline
- Start date
- 2024-06-20
- Primary completion
- 2026-06-01
- Completion
- 2029-06-01
- First posted
- 2024-07-29
- Last updated
- 2024-07-29
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT06526065. Inclusion in this directory is not an endorsement.